Bharat Book Bureau

Archives for generic

As majority of the blockbuster drugs are set to go off patent in the next few years, $140 bn injectables market is set to assume prominence as the fastest growing and the most preferred drug delivery mode in place of oral formulations. Relatively high insulation from competition post off- patent stage, strong entry barriers, high… » read more

Posted by bharatbook

Cancer Generics Market Analysis Cancer has emerged as one of the major causes of death globally and has made the pharmaceutical & biotech companies proactive to foray research & development to develop new therapies for its treatment. With increasing cancer incidences and competition in the healthcare industry around the world, the cancer market represents a… » read more

Posted by bharatbook

Global miRNA Market Outlook The upcoming field of miRNA research has been one of the most prolific contributors to modern medicine in recent times. Still at its nascent stage, miRNA research has helped the medical science community in understanding the dynamics of various diseases from a different perspective. After heavy focus on research for the… » read more

Posted by bharatbook

Bharatbook added a new report on “Active Pharmaceutical Ingredients (APIs) Market to 2015 – Rise in the Generic and Biotech Sector will Sustain Growth” into its market report catalogue for reselling. Active Pharmaceutical Ingredients (APIs) Market to 2015 – Rise in the Generic and Biotech Sector will Sustain Growth The report provides a detailed insight… » read more

Posted by bharatbook

Bharatbook added a new report on “Booming US Generic Drug Market” which provides rational analysis of various factors which will drive the generics market in the US. By RNCOS. Booming US Generic Drug Market The US represents one of the world’s largest economies. The countries per capita income and spending are rated among the highest… » read more

Posted by bharatbook

The pharmaceutical industry is facing an impending patent cliff, when some of its biggest selling drugs will lose patent protection and become exposed to generic competition. Big Pharma seeks to insulate itself from impact of patent cliff The pharmaceutical industry is facing an impending patent cliff, when some of its biggest selling drugs will lose… » read more

Posted by bharatbook